Kate S. Carroll is a Professor in the Department of Chemistry at the Herbert Werthheim UF Scripps Institute for Biomedical Innovation and Technology. She is currently the Program Chair for the American Chemical Society Division of Biological Chemistry and an Associate Editor of Free Radical Biology and Medicine. Among her honors are selection as a Camille Dreyfus Teacher-Scholar, Leukemia & Lymphoma Society Research Scholar, and the ACS Pfizer Award in Enzyme Chemistry. The Carroll Research Group is focused on redefining druggability in the cysteine redoxome, using chemoproteomic platforms to tackle the undruggable proteome.